9 Ways Estrogen Loss Destabilizes Connective Tissue and Why Hypermobile Women Are Hit Hardest
The women who reach out about this topic are often the ones who spent decades being told they were 'just flexible' or 'a bit bendy' — and who suddenly, in their mid-forties, find themselves spraining ankles on flat ground or waking up with subluxed shoulders. It's not in your head, and it's not aging in the usual sense. The estrogen connection is real, it's measurable, and knowing about it changes everything about how you manage it.
Learn more about Rose →Estrogen Directly Regulates Collagen Synthesis
Estrogen receptors sit on fibroblasts — the cells responsible for producing collagen — and when estrogen binds to them, it upregulates the genes that drive collagen production. As estrogen declines in perimenopause, fibroblast activity slows, and the body produces less new collagen to replace what naturally degrades. Studies using skin biopsy data show that women lose roughly 30% of dermal collagen in the first five years after menopause, a figure that reflects what is happening in tendons, ligaments, and joint capsules simultaneously.
Collagen Cross-Linking Weakens, Reducing Tensile Strength
Collagen doesn't work as isolated fibers — its strength comes from cross-links between adjacent strands that make the matrix dense and resistant to stretch. Estrogen promotes the enzymatic processes that form these cross-links, particularly through lysyl oxidase activity. When estrogen drops, cross-linking becomes less efficient, producing collagen that is structurally looser and more prone to microtear under load — a change that translates directly into ligament laxity and reduced joint stability.
The Collagen Type I to Type III Ratio Shifts Unfavorably
Healthy tendons and ligaments are predominantly Type I collagen — dense, organized, high-tensile fibers built for load-bearing. Type III collagen is softer, more elastic, and less structurally robust; it dominates in fetal tissue and wound healing. Evidence from animal models and some human tissue studies suggests that estrogen loss shifts the balance toward relatively more Type III collagen in connective tissue, making structures more compliant and less capable of restraining joint movement under stress.
Relaxin Sensitivity May Increase as Estrogen Falls
Relaxin is a hormone that deliberately loosens connective tissue — its best-known role is softening the pelvis during pregnancy. Estrogen appears to modulate tissue sensitivity to relaxin, and some researchers propose that falling estrogen removes a protective buffer, leaving connective tissue more responsive to relaxin's laxity-promoting effects. For hypermobile women, whose tissue is already operating at the permissive end of the spectrum, any upward shift in effective relaxin sensitivity can have outsized consequences for joint stability.
Synovial Fluid Production Decreases, Reducing Joint Lubrication
The synovial membrane lining joints produces hyaluronic-acid-rich fluid that lubricates cartilage surfaces and absorbs shock. Estrogen receptors are present in synovial tissue, and estrogen loss is associated with reduced synovial fluid volume and altered viscosity. The result is increased friction between joint surfaces — contributing to the grinding, clicking, and early-morning stiffness that many perimenopausal women notice, and adding mechanical stress to ligaments that are already losing collagen integrity.
Inflammation in Connective Tissue Rises Without Estrogen's Anti-Inflammatory Brake
Estrogen has well-documented anti-inflammatory properties, partly by suppressing pro-inflammatory cytokines including interleukin-1 and TNF-alpha in joint tissues. As estrogen withdraws, local inflammatory tone in tendons, bursae, and joint capsules tends to rise — a shift that accelerates collagen degradation via matrix metalloproteinases (MMPs), enzymes that break down the extracellular matrix. For hypermobile women, inflamed connective tissue that was already structurally lax becomes both more painful and more vulnerable to injury.
Proprioception Degrades as Mechanoreceptors in Ligaments Lose Estrogen Support
Ligaments aren't passive restraints — they contain mechanoreceptors that continuously signal the brain about joint position, load, and movement speed. These sensory neurons have estrogen receptors, and animal studies show that estrogen withdrawal impairs their sensitivity and firing frequency. Degraded proprioception means the neuromuscular system receives less accurate joint-position data and responds more slowly to destabilizing forces — a particularly serious problem for hypermobile women whose joints already have a wider-than-average range of movement to monitor and control.
Muscle Mass and Tone Decline, Removing the Primary Backup Stabilization System
In women with hypermobility, muscles do heavy compensatory work — they contract protectively around loose joints to provide the stability that ligaments cannot. Estrogen supports muscle protein synthesis and the maintenance of fast-twitch muscle fibers, and its loss contributes to sarcopenia that begins accelerating in perimenopause. When the muscles that were quietly bracing unstable joints lose mass and reactivity, joint subluxations, sprains, and pain flares become significantly more frequent — the redundancy system that kept symptoms manageable disappears.
The Hypermobile Nervous System Amplifies Every Signal — Including Pain
Hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome (hEDS) are increasingly associated with altered central pain processing and heightened nervous system sensitivity, independent of joint laxity alone. Estrogen modulates pain perception centrally — it influences serotonin, norepinepherine, and opioid pathways that regulate how intensely pain signals are experienced. When estrogen falls, already-sensitized nervous systems in hypermobile women lose an important pain-dampening influence, which is why many report that their pain becomes both more widespread and harder to explain to clinicians who focus only on structural findings.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.